Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.
暂无分享,去创建一个
Chris Cheadle | Kevin G Becker | K. Becker | D. Teichberg | C. Cheadle | P. Morin | C. Sherman-Baust | Patrice J Morin | G Peter Sawiris | Cheryl A Sherman-Baust | Diane Teichberg | G. P. Sawiris
[1] R. Fisher,et al. Chemotherapy of ovarian cancer. , 1978, The Surgical clinics of North America.
[2] L. Dubeau. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? , 1999, Gynecologic oncology.
[3] J. Sudbø,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[4] M. Ko,et al. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] C. Garrett,et al. Protooncogene amplification and tumor ploidy in human ovarian neoplasms. , 1990, Human pathology.
[6] J. Guastalla,et al. [Advanced ovarian cancer]. , 1995, Soins; la revue de reference infirmiere.
[7] D R Schwartz,et al. Coordinately up-regulated genes in ovarian cancer. , 2001, Cancer research.
[8] P. Kaldis,et al. Analysis of CAK activities from human cells. , 2000, European journal of biochemistry.
[9] R. Spang,et al. Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] N. Niikawa,et al. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. , 1998, American journal of medical genetics.
[11] X. Matías-Guiu,et al. Molecular pathology of ovarian carcinomas , 1998, Virchows Archiv.
[12] F. Casagrande,et al. Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes. , 1998, Investigative ophthalmology & visual science.
[13] G. Riggins,et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. , 2000, Cancer research.
[14] P. Pharoah,et al. Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers , 2000, International journal of cancer.
[15] R. L. Baldwin,et al. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. , 2000, Cancer research.
[16] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Burg. Advanced ovarian cancer , 2001, Current treatment options in oncology.
[18] A. Schäffer,et al. Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis , 2000, Genes, chromosomes & cancer.
[19] Roger E Bumgarner,et al. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. , 1999, Gene.
[20] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[21] D. Lockhart,et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Bartek,et al. Expression of CDK7/CAK in normal and tumour cells of diverse histogenesis, cell‐cycle position and differentiation , 1996, International journal of cancer.
[23] D. Katsaros,et al. Transforming growth factor-beta isoform expression in human ovarian tumours. , 1997, European journal of cancer.
[24] G. Getz,et al. Coupled two-way clustering analysis of gene microarray data. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Ngan,et al. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] K. Alitalo,et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells , 1993, The Journal of experimental medicine.
[27] S. Rafii,et al. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Hartmann,et al. Human epithelial ovarian cancer allelotype. , 1993, Cancer research.
[29] J. Berek,et al. Advanced ovarian cancer. Tumour markers. , 1993, Annals of Oncology.
[30] M Aickin,et al. Chromosome abnormalities in ovarian adenocarcinoma: I. nonrandom chromosome abnormalities from 244 cases , 1999, Genes, chromosomes & cancer.
[31] N. Auersperg,et al. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. , 1999, Proceedings of the National Academy of Sciences of the United States of America.